Black Diamond Therapeutics Inc. (NASDAQ: BDTX)
$6.02
+0.3700 ( +6.55% ) 360.5K
Black Diamond Therapeutics Inc is a precision oncology medicine company. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.
Market Data
Open
$6.02
Previous close
$5.65
Volume
360.5K
Market cap
$338.73M
Day range
$5.70 - $6.05
52 week range
$1.62 - $7.66
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
4 | Insider transactions | 1 | Jun 21, 2024 |
4 | Insider transactions | 1 | Jun 21, 2024 |
4 | Insider transactions | 1 | Jun 21, 2024 |
4 | Insider transactions | 2 | Jun 06, 2024 |
4 | Insider transactions | 1 | Jun 06, 2024 |
4 | Insider transactions | 1 | Jun 06, 2024 |
4 | Insider transactions | 1 | Jun 06, 2024 |
4 | Insider transactions | 1 | Jun 06, 2024 |
4 | Insider transactions | 1 | Jun 06, 2024 |
8-k | 8K-related | 14 | Jun 06, 2024 |